XLV vs XPH
YTDYear to date
XLV wins+2.5 pts
Past year
XPH wins+8.1 pts
Fee
XLV winslower fee
Yield
XLV wins+0.9 pts
AUM
XLV104.1× more
3–1XLV wins
XLV and XPH · year-to-date · as of Nov 10, 2026 · AUM not scored
XPH vs S&P 500
1D$67.37 · +4.0% last sessionDividend-adjusted total return. S&P 500 uses VOO.CompareS&P 500+ Peer avg+ Add a fund
Return1D ▼1M3MYTD1Y3Y5YMAX
Total return+4.0%+4.2%−3.3%+20.6%+39.3%+91.1%+46.7%+444.6%
Peer average+2.4%+6.4%+5.5%+23.4%+33.1%+76.7%+28.9%—
S&P 500 · VOO+2.3%−3.3%−2.1%+11.3%+13.6%+81.6%+75.4%+814.2%
SPDR XPH and Vanguard VOO · total return, dividends in · as of Nov 10, 2026
XPH’s Holdings
Today[…] The fund reports no holdings yet.
All 39 Health Care ETFs
YTD| # | Trend | |||||||
|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDRReadDesk | 0.08% | 1.4% | +23.2% | +23.2% | $49.7B | |
| 2 | VHT | Health CareReadDesk | 0.09% | 1.3% | +22.2% | +22.2% | $19.1B | |
| 3 | XBI | State Street SPDR S&P BiotechReadDesk | 0.35% | 0.3% | +28.8% | +28.8% | $10.3B | |
| 4 | IYH | U.S. HealthcareReadDesk | 0.37% | 1.0% | +22.4% | +22.4% | $4.8B | |
| 5 | IXJ | Global HealthcareReadDesk | 0.38% | 1.3% | +19.1% | +19.1% | $4.7B | |
| 6 | IHI | U.S. Medical DevicesReadDesk | 0.37% | 0.4% | −5.4% | −5.4% | $4.1B | |
| 7 | FHLC | Fidelity MSCI Health CareReadDesk | 0.08% | 1.1% | +22.4% | +22.4% | $4.0B | |
| 8 | ARKG | ARK Genomic RevolutionReadDesk | 0.75% | — | +66.6% | +66.6% | $2.2B | |
| 9 | IHE | U.S. PharmaceuticalsReadDesk | 0.37% | 1.3% | +26.8% | +26.8% | $1.7B | |
| 10 | IHF | U.S. Healthcare ProvidersReadDesk | 0.37% | 0.9% | +24.4% | +24.4% | $1.5B | |
| 11 | PBPH | Portfolio Building Block World Pharma and BiotechReadDesk | 0.13% | 0.1% | +25.6% | +25.6% | $1.3B | |
| 12 | FTXH | First Trust Nasdaq PharmaceuticalsReadDesk | 0.60% | 0.7% | +35.3% | +35.3% | $1.2B | |
| 13 | FXH | First Trust Health Care AlphaDEXReadDesk | 0.61% | 0.5% | +23.1% | +23.1% | $1.2B | |
| 14 | PPH | VanEck PharmaceuticalReadDesk | 0.36% | 1.8% | +19.6% | +19.6% | $1.1B | |
| 15 | PJP | PharmaceuticalsReadDesk | 0.58% | 0.9% | +25.0% | +25.0% | $584M | |
| 16 | BBH | VanEck BiotechReadDesk | 0.35% | 0.4% | +37.1% | +37.1% | $524M |
1–16 of 39Page 1 of 3
Health Care · current AUM · as of Nov 10, 2026
XPH Payouts by Year
13YLatest payout, Sep 2026
$0.04
a share · every quarter
0.4% yield
0.4% yield
13 years added up
$10.92 a share
$10.92 a share
SPDR XPH · per-share distributions by ex-date · 2014–2026
XPH’s Peers
YTD| # | Trend | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | XLV | State Street Health Care Select Sector SPDR ETFReadVersus | 0.08% | 1.4% | +1.9% | +23.2% | +31.2% | $49.7B | |
| 2 | VHT | Vanguard Health Care ETFReadVersus | 0.09% | 1.3% | +2.0% | +22.2% | +29.9% | $19.1B | |
| 3 | XBI | State Street SPDR S&P Biotech ETFReadVersus | 0.35% | 0.3% | +3.1% | +28.8% | +44.2% | $10.3B | |
| 4 | IYH | iShares U.S. Healthcare ETFReadVersus | 0.37% | 1.0% | +2.0% | +22.4% | +30.4% | $4.8B | |
| 5 | IXJ | iShares Global Healthcare ETFReadVersus | 0.38% | 1.3% | +1.8% | +19.1% | +27.0% | $4.7B | |
| 6 | XPH | State Street SPDR S&P Pharmaceuticals ETFThis fund | 0.35% | 0.4% | +4.0% | +20.6% | +39.3% | $477M |
#18 of 33 this year · #11 cheapest of 39 · sorted by assetsOpen the Sectors table →
XPH and its peer group · total return · as of Nov 10, 2026
Cards for This View
XPH’s Top 10 Holdings
TodayXPH reports no holdings we can show: […]
XPH vs Peer Average
YTDXPHAvsBPeer average
1D+4.0%+2.4%
1M+4.2%+6.4%
3M−3.3%+5.5%
YTD+20.6%+23.4%
1Y+39.3%+33.1%
3Y+91.1%+76.7%
5Y+46.7%+28.9%
4–3XPH wins
38 Health care peers · each row scaled to its leader